This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
EMD Millipore
other brands :
Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava
product type :
antibody
product name :
AFP Antibody, clone 1E4
catalog :
MABD78
quantity :
100 μg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
1E4
reactivity :
human
application :
western blot
product information
Catalog Number :
MABD78
Subcategory :
Stem Cell Research
Product Name :
Anti-AFP Antibody, clone 1E4
Product Type :
Antibodies
Clonality :
Monoclonal Antibody
Gene ID :
P02771
Host Name :
Mouse
Antigen :
AFP
Clone :
1E4
Conjugate :
Purified
Isotype :
IgG2aκ
Product Description :
Anti-AFP Antibody, clone 1E4
Cross Reactivity :
Human
Background :
AFP (alpha-fetoprotein) is a fetal serum protein that shows an increased expression in many different clinical conditions and has been associated with hepatocellular carcinoma and germ cell tumors. It has also been linked to the development of gastric cancer. Women with pregestational diabetes have commonly shown a decrease in maternal serum AFP during the second trimester. AFP has been used as a pregnancy monitoring biomarker in many different mammalian species.
ALT Names :
Alpha-fetoprotein;Alpha-1-fetoprotein;Alpha-fetoglobulin
Immunogen :
Recombinant protein corresponding to human AFP.
Package Size :
100 μg
Uses :
Western Blotting
Storage :
Stable for 1 year at 2-8°C from date of receipt
company information
EMD Millipore
290 Concord Road
Billerica, Massachusetts 01821
Billerica, Massachusetts 01821
bioscienceshelp@emdchemical.com
https://www.emdmillipore.com888-854-3417
headquarters: United States
EMD Millipore is the Life Science division of Merck KGaA of Darmstadt, Germany
Hundreds of New Antibodies in the areas of:
View all the new antibodies at www.emdmillipore.com.
Hundreds of New Antibodies in the areas of:
|
|
questions and comments